Two key chiral intermediates in a new 4‐hydroxy­isoleucine synthesis

We present the crystal and molecular structure of two key compounds of a new synthesis strategy for isomers of natural (2S,3R,4S)‐4‐hydroxyisoleucines, 2,3,5,6,7,8‐hexa­hydro‐3‐(1‐hydroxy‐1‐methyl‐2‐oxo­propyl)‐6,8‐methano‐7,7,8a‐tri­meth­yl‐5H‐1,4‐benzoxazin‐2‐one, C₁₆H₂₃NO₄, and 2,3,5,6,7,8‐hexa­hydro‐3‐(1‐methyl‐2‐oxo­propyl)‐6,8‐methano‐7,7,8a‐tri­meth­yl‐5H‐1,4‐benzoxazin‐2‐one, C₁₆H₂₃NO₃. A new optically pure chiral oxazinone auxiliary derived from (1R,2R,5R)‐2‐hydroxy­pinan‐3‐one was used.     

Tylophorine B benzene solvate

The crystal structure of tylophorine B (or 2,3,6‐tri­methoxy­phen­an­thro­[9,10‐f]­indol­izidine) as the benzene solvate, C₂₃H₂₅NO₃·­C₆H₆, has been determined. The compound was isolated from albizzia julibrissin and this is the first definitive report of the steochemistry of tylo­phorine.     

Three 5H‐indeno­[1,2‐c]­pyridazin‐5‐one derivatives,potent type‐B mono­amine oxidase inhibitors

The structures of three compounds, namely 7‐methoxy‐2‐[3‐(tri­fluoro­methyl)­phenyl]‐9H‐indeno­[1,2‐c]­pyridazin‐9‐one, C₁₉H₁₁F₃N₂O₂, (Id), 6‐methoxy‐2‐[3‐(tri­fluoro­methyl)­phenyl]‐9H‐indeno­[1,2‐c]­pyridazin‐9‐one, C₁₉H₁₁F₃N₂O₂, (IId), and 2‐methyl‐6‐(4,4,4‐tri­fluoro­butoxy)‐9H‐indeno­[1,2‐c]­pyridazin‐9‐one, C₁₆H₁₃F₃N₂O₂, (IIf), which are potent reversible type‐B mono­amine oxidase (MAO‐B) inhibitors, are presented and discussed. Compounds (Id) and (IId) crystallize in a nearly planar conformation. The crystal structures are stabilized by weak C—H⋯O hydrogen bonds. The packing is dominated by π–π stacking interactions between the heterocyclic central moieties of centrosymmetrically related mol­ecules. In compound (IIf), the tri­fluoro­ethyl termination is almost perpendicular to the plane of the ring.     

Four tri­fluoro­methyl­nitro­benzene analogues

The crystal structures of four tri­fluoro­methyl­nitro­benzene analogues (CF₃)C₆H₃(NO₂)[C₄H₈N₂]R (where C₄H₈N₂ is piperazinyl and R is ethyl carboxyl­ate, CO₂C₂H₅, or phenyl, C₆H₅), have been determined, and their conformations and packing arrangements are compared. The four compounds are ethyl 4‐[4‐nitro‐2‐(tri­fluoro­methyl)­phenyl]­piperazine‐1‐car­boxyl­ate, (I), and ethyl 4‐[2‐nitro‐4‐(tri­fluoro­methyl)­phen­yl]piper­azine‐1‐carboxyl­ate, (II), both C₁₄H₁₆F₃N₃O₄, and 1‐­[4‐nitro‐2‐(tri­fluoro­methyl)­phenyl]‐4‐phenyl­piperazine, (III), and 1‐[2‐nitro‐4‐(tri­fluoro­methyl)­phenyl]‐4‐phenyl­piperazine, (IV), both C₁₇H₁₆F₃N₃O₂. All mol­ecules adopt a rod‐like conformation, while the asymmetric units of (II) and (IV) contain two unique mol­ecules that pack as monodirectional pairs. All mol­ecules pack with C—H⋯O/F close contacts to all but one of the O atoms and to five of the 18 F atoms.     

Samaderin B and C from Samadera indica

Samaderin B, or (1R,2S,5R,5aR,7aS,11S,11aS,11bR,14S)‐1,7,7a,11,11a,11b‐hexa­hydro‐1,11‐di­hydroxy‐8,11a,14‐tri­methyl‐2H‐5a,2,5‐(methan­oxy­metheno)­naphth­[1,2‐d]­oxepine‐4,6,10(5H)‐trione, C₁₉H₂₂O₇, and samaderin C, or (1R,2S,5R,5aR,7aS,10S,11S,11aS,11bR,14S)‐7,7a,10,11,11a,11b‐hexa­hydro‐1,10,11‐tri­hydroxy‐8,11a,14‐tri­methyl‐2H‐5a,2,5‐(methan­oxy­metheno)­naphth­[1,2‐d]­oxepine‐4,6(1H,5H)‐dione, C₁₉H₂₄O₇, were isolated from the seed kernels of Samadera indica and were shown to exhibit antifeedant activity against Spodoptera litura third‐instar larvae. The replacement of the carbonyl group in samaderin B by a hydroxy group in samaderin C causes conformational changes at the substitution site, but the overall conformation is not affected; however, the compounds pack differently in the crystal lattice.     

Exo Diels–Alder adducts between ortho‐ and para‐N‐acetoxy­phenyl­male­imides and furan

In exo‐2‐(3,5‐dioxo‐10‐oxa‐4‐aza­tri­cyclo­[5.2.1.0^2,6]­dec‐8‐en‐4‐yl)­phenyl acetate, C₁₆H₁₃NO₅, the plane of the acetoxy group lies almost perpendicular to that of the phenyl ring [dihedral angle = 89.8 (1)°], in contrast with the smaller deviations found in the para isomer exo‐4‐(3,5‐dioxo‐10‐oxa‐4‐aza­tri­cyclo­[5.2.1.0^2,6]­dec‐8‐en‐4‐yl)­phenyl acetate, C₁₆H₁₃NO₅, these being 63.6 (1) and 37.0 (1)° for the two crystallographically independent mol­ecules. Irrespective of the position of the acetoxy group, both compounds pack through soft C—H⋯X (X is O or phenyl) interactions, forming interlinked centrosymmetric tetramers in the bc plane.     

Three methoxy‐substituted diethyl 4‐­phenyl‐2,6‐di­methyl‐1,4‐di­hydro­pyridine‐3,5‐di­carboxyl­ate compounds

Diethyl 4‐(2,5‐di­methoxy­phenyl)‐2,6‐di­methyl‐1,4‐di­hydro­pyridine‐3,5‐di­carboxyl­ate, C₂₁H₂₇NO₆, (I), diethyl 4‐(3,4‐di­methoxy­phenyl)‐2,6‐di­methyl‐1,4‐di­hydro­pyridine‐3,5‐di­carboxyl­ate, C₂₁H₂₇NO₆, (II), and diethyl 2,6‐di­methyl‐4‐(3,4,5‐tri­methoxy­phenyl)‐1,4‐di­hydro­pyridine‐3,5‐di­carboxyl­ate, C₂₂H₂₉NO₇, (III), crystallize with hydrogen‐bonding networks involving the H atom bonded to the N atom of the 1,4‐di­hydro­pyridine ring and carbonyl O atoms in (I) and (II). Unusually, (III) shows O atoms of methoxy groups serving as hydrogen‐bond acceptors.     

2‐Acetamido‐N‐benz­yl‐2‐(methoxy­amino)acetamides: functionalized amino acid anticonvulsants

In the crystal structure of 2‐acetamido‐N‐benz­yl‐2‐(methoxy­amino)acetamide (3L), C₁₂H₁₇N₃O₃, the 2‐acetyl­amino­acetamide moiety has a linearly extended conformation, with an inter­planar angle between the two amide groups of 157.3 (1)°. In 2‐acetamido‐N‐benz­yl‐2‐[meth­oxy(meth­yl)­amino]­acetamide (3N), C₁₃H₁₉N₃O₃, the planes of the two amide groups inter­sect at an angle of 126.4 (4)°, resulting in a chain that is slightly more bent. The replacement of the methoxy­amino H atom of 3L with a methyl group to form 3N and concomitant loss of hydrogen bonding results in some positional/thermal disorder in the meth­oxy­(methyl)­amino group. In both structures, in addition to classical N—H⋯O hydrogen bonds, there are also weak non‐standard C—H⋯O hydrogen bonds. The hydrogen bonds and packing inter­actions result in planar hydro­philic and hydro­phobic areas perpendicular to the c axis in 3L and parallel to the ab plane in the N‐meth­yl derivative. Stereochemical comparisons with phenytoin have identified two O atoms and a phenyl group as mol­ecular features likely to be responsible for the anticon­vulsant activities of these compounds.     

Rotenone α‐oxime

The structure determination of the title compound, rotenone α‐oxime [systematic name: 1,2,12,12a‐tetra­hydro‐8,9‐di­meth­oxy‐2‐(1‐methyl­ethenyl)‐[1]­benzo­py­rano­[3,4‐b]­furo­[2,3‐h][1]benzo­pyran‐6(6H)‐one oxime], C₂₃H₂₃NO₆, confirms that the mol­ecule has an approximately V‐shaped structure. One of the rings has a typical cyclo­hexene‐like monoplanar conformation and the central ring adopts a 1,2‐diplanar conformation.     

Four bromo‐substituted pyrazoline and isoxazolinone spiro derivatives

Conformational analyses and a structural comparison of the four spiro compounds 3‐bromo‐1,9‐di­phenyl‐4‐p‐tolyl‐7‐oxa‐1,2,8‐tri­aza­spiro­[4.4]­nona‐2,8‐dien‐6‐one, (I), C₂₄H₁₈BrN₃O₂, 3‐bromo‐4‐(4‐methoxy­phenyl)‐1,9‐di­phenyl‐7‐oxa‐1,2,8‐tri­aza­spiro­[4.4]­nona‐2,8‐dien‐6‐one, (II), C₂₄H₁₈BrN₃O₃, 3‐bromo‐4‐(4‐chloro­phenyl)‐1,7,9‐tri­phenyl‐1,2,7,8‐tetra­aza­spiro­[4.4]­nona‐2,8‐dien‐6‐one, (III), C₂₉H₂₀BrClN₄O, and 3‐bromo‐1,7,9‐tri­phenyl‐4‐p‐tolyl‐1,2,7,8‐tetra­aza­spiro­[4.4]­nona‐2,8‐di­en‐6‐one, (IV), C₃₀H_22.89Br_1.11N₄O, are presented. The mol­ecular structures are rather similar, which is as expected since the compounds are all products of concerted 1,3‐dipolar attack on (Z)‐4‐aryl­idene oxazolone and pyrazolone derivatives. The observed conformations tend to favour extended π conjugation of the benzene rings and other π systems, as shown by a comparison of selected geometric parameters of the four structures.     

(Z)‐2‐Methylbuten‐1‐yl(aryl)iodonium trifluoromethanesulfonates containing electron‐withdrawing groups on the aryl moiety

The crystal structures of [(Z)‐2‐methyl­but‐1‐en‐1‐yl]­[4‐(tri­fluoro­methyl)­phenyl]­iodo­nium tri­fluoro­methane­sulfonate, C₁₂H₁₃F₃I⁺·CF₃O₃S^?, (I), (3,5‐di­chloro­phenyl)­[(Z)‐2‐methyl­but‐1‐en‐1‐yl]­iodo­nium tri­fluoro­methane­sulfonate, C₁₁H₁₂­Cl₂I⁺·CF₃O₃S^?, (II), and bis{[3,5‐bis­(tri­fluoro­methyl)­phenyl][(Z)‐2‐methyl­but‐1‐en‐1‐yl]­iodo­nium} bis­(tri­fluoro­methane­sulfonate) di­chloro­methane solvate, 2C₁₃H₁₂F₆I⁺·­2CF₃­O₃S^?·CH₂Cl₂, (III), are described. Neither simple acyclic β,β‐di­alkyl‐substituted alkenyl­(aryl)­idonium salts nor a series containing electron‐deficient aryl rings have been described prior to this work. Compounds (I)–(III) were found to have distorted square‐planar geometries, with each I atom interacting with two tri­fluoro­methane­sulfonate counter‐ions.     

Structural properties of a series of photochromic fluorinated indolylfulgides

Fluorinated indolyl­fulgides are a class of photochromic organic compounds that meet many of the requirements for use as optical memory media and optical switches. The X‐ray crystal structures of a series of five photochromic fluorinated indolyl­fulgides have been determined, namely (3Z)‐3‐[1‐(1,2‐di­methyl‐1H‐indol‐3‐yl)‐2,2,2‐tri­fluoro­ethyl­idene]‐4‐(1‐methyl­ethyl­idene)­dihydrofuran‐2,5‐dione (tri­fluoro­methyl­iso­propyl­idene­indolyl­fulgide), C₁₉H₁₆F₃NO₃, (I), (3Z)‐3‐[1‐(1,2‐dimethyl‐1H‐indol‐3‐yl)‐2,2,3,3,3‐penta­fluoro­propyl­idene]‐4‐(1‐methyl­ethyl­idene)­dihydrofuran‐2,5‐dione (penta­fluoro­ethyl­iso­propyl­idene­indolyl­fulgide), C₂₀H₁₆F₅NO₃, (II), (3Z)‐3‐[1‐(1,2‐di­methyl‐1H‐indol‐3‐yl)‐2,2,3,3,4,4,4‐hepta­fluoro­butyl­idene]‐4‐(1‐methyl­ethyl­idene)­dihydrofuran‐2,5‐dione (hepta­fluoro­propyl­iso­propyl­idene­indolyl­fulgide), C₂₁H₁₆F₇NO₃, (III), (3Z)‐3‐[1‐(1,2‐di­methyl‐1H‐indol‐3‐yl)‐2,2,2‐tri­fluoro­ethyl­idene]‐4‐(tri­cyclo­[3.3.1.1^3,7]­decyl­idene­)dihydrofuran‐2,5‐dione (tri­fluoro­methyl­adamantyl­idene­indolyl­fulgide), C₂₆H₂₄F₃NO₃, (IV), and (3Z)‐3‐[1‐(1,2‐di­methyl‐1H‐indol‐3‐yl)‐2,2,3,3,4,4,4‐hepta­fluoro­butyl­idene]‐4‐(tri­cyclo­[3.3.1.1^3,7]­decyl­idene­)dihydrofuran‐2,5‐dione (hepta­fluoro­propyl­adamantylidenein­dolyl­fulgide), C₂₈H₂₄F₇NO₃, (V). The photochromic property of fulgides is based on the photochemically allowed electrocyclic ring closure of a hexatriene system to form a cyclo­hexa­diene. For each fulgide examined, the bond lengths within the hexatriene system alternate between short and long, as expected. Comparing the structures of the five fulgides with each other demonstrates no significant difference in bond lengths, bond angles or dihedral angles within the hexatriene systems. The distance between the bond‐forming C atoms at each end of the hexatriene system does vary. Correlations of structural properties with optical properties are addressed.     

Bis(2,5‐dimethoxy‐4‐methylphenyl)methane and bis(2,5‐dimethoxy‐3,4,6‐trimethylphenyl)methane

Bis(2,5‐di­methoxy‐4‐methyl­phenyl)­methane, C₁₉H₂₄O₄, (IIa), was obtained and characterized as a minor product from the reaction of tolu­hydro­quinone di­methyl ether (1,4‐dimethoxy‐2‐methylbenzene) with N‐(hydroxy­methyl)­tri­fluoro­acet­amide. Similarly, bis(2,5‐di­methoxy‐3,4,6‐tri­methyl­phenyl)­methane, C₂₃H₃₂O₄, (IIb), was prepared from the corresponding reaction of tri­methyl­hydro­quinone di­methyl ether (2,5‐dimethoxy‐1,3,4‐trimethylbenzene). The mol­ecules of (IIa) and (IIb) each lie on a twofold axis passing through the methyl­ene group. The dihedral angle between the planar phenyl rings is 73.4 (1)° in (IIa) and 77.9 (1)° in (IIb). The external bond angles around the bridging methyl­ene group are 116.6 (2) and 117.3 (2)° for (IIa) and (IIb), respectively. In (IIa), the methoxy substituents lie in the plane of the ring and are conjugated with the aromatic system, whereas in (IIb), they are almost perpendicular to the phenyl ring and are positioned on opposite sides.     

The antifolate trimetrexate: ­observation of the enzyme‐binding conformation

The crystal structure of the title compound contains four 2,4‐di­amino‐5‐methyl‐6‐[(3,4,5‐tri­methoxy­anilino)­methyl]­quin­az­oline mol­ecules, two di­methyl sulfoxide mol­ecules and three water mol­ecules in the asymmetric unit, i.e. 4C₁₉H₂₃N₅O₃·2C₂H₆OS·3H₂O. All four quinazoline mol­ecules adopt trans,gauche conformations. An extensive hydrogen‐bond network involving N?N base‐pairing interactions, as well as the di­methyl sulfoxide and water mol­ecules, stabilizes the crystal structure.     

Linear chains in polymeric di­cyclo­hexyl­ammonium tri­butyl­(4‐oxo‐4H‐pyran‐2,6‐di­carboxyl­ato)­stannate and methyl­phenyl­ammonium tri­butyl(pyridine‐2,6‐di­carboxyl­ato)­stannate containing trigonal bipyramidal tin

catena‐Poly­[di­cyclo­hexyl­ammonium [tri­butyl­tin‐μ‐(4‐oxo‐4H‐pyran‐2,6‐di­carboxyl­ato‐O²:O⁶)]], (C₁₂­H₂₄N)­[Sn(C₇­H₂­O₆)(C₄H₉)₃], consists of 4‐oxo‐4H‐pyran‐2,6‐di­carboxyl­ato groups that axially link adjacent tri­butyl­tin units into a linear polyanionic chain. The ammonium counter‐ions surround the chain, and each cation forms a pair of hydrogen bonds to the double‐bond carbonyl O atoms of the same dianionic group. The chain propagates in a zigzag manner along the c axis of the monoclinic cell. In catena‐poly­[methyl­(phenyl)­ammonium [tri­butyl­tin‐μ‐(pyridine‐2,6‐di­carboxyl­ato‐O²:O⁶)]], (C₇H₁₀N)­[Sn(C₇H₃NO₄)­(C₄H₉)₃], the pyridine‐2,6‐di­carboxyl­ato groups also link the tri­butyl­tin groups into a chain, but the hydrogen‐bonded chain propagates linearly on the ac face of the monoclinic cell.     

X‐ray investigations of sulfur‐containing fungicides. IV. 4′‐{[Benzoyl(4‐chlorophenylhydrazono)methyl]sulfonyl}acetanilide and 4′‐{[benzoyl(4‐methoxyphenylhydrazono)methyl]sulfonyl}acetanilide

The conformations of the two approximately isomorphous structures 4′‐{[benzoyl(4‐chloro­phenyl­hydrazono)­methyl]­sul­fonyl}acetanilide, C₂₂H₁₈ClN₃O₄S, and 4′‐{[benzoyl(4‐meth­oxy­phenyl­hydrazono)­methyl]­sulfonyl}acetanilide, C₂₃H₂₁N₃­O₅S, are stabilized by resonance‐assisted intramolecular hydrogen bonds linking the hydrazone moieties and sulfonyl groups. The stronger bond is observed in the former compound. The difference in electronic properties between the Cl atom and the methoxy group is too small to significantly alter the non‐bonding interactions of the sulfonyl and β‐­carbonyl groups.     

Astemizole tetra­chloro­cuprate(II)

The structure of {3‐[(4‐fluoro­phenyl)­methyl]‐1H‐benzimidazol‐2‐ylidene}{1‐[2‐(4‐meth­oxy­phenyl)­ethyl]‐4‐piperidin‐1‐io}ammonium tetra­chloro­cuprate(II), (C₂₈H₃₃FN₄O)[CuCl₄], contains diprotonated cations of astemizole hydrogen bonded to three Cl atoms in two different CuCl₄^2? anions, with Cl?N distances in the range 3.166 (4)–3.203 (4) Å. The geometry around copper is flattened tetrahedral with significantly different Cu—Cl distances which lie in the range 2.1968 (14)–2.2861 (12) Å. The phenyl­ethyl C atoms of the (4‐methoxy­phenyl­)ethyl group are disordered indicating the presence of two conformers in the crystals.     

1‐[4‐(Methyl­sulfonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole derivatives

Three related compounds containing a pyrazole moiety with vicinal phenyl rings featuring a methyl­sulfonyl substituent are described, namely 3‐methyl‐1‐[4‐(methyl­sulfonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole, C₁₇H₁₆N₂O₂S, ethyl 1‐[4‐(methyl­sul­fonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole‐3‐carboxyl­ate, C₁₉H₁₈N₂O₄S, and 1‐[4‐(methyl­sulfonyl)­phenyl]‐3‐[3‐(morpholino)­phenoxy­methyl]‐5‐phenyl‐1H‐pyrazole, C₂₇H₂₇N₃O₄S. The design of these compounds was based on celecoxib, a selective cyclo­oxy­genase‐2 (COX‐2) inhibitor, in order to study the influence of various substituents on COX‐2 and 5‐lipoxy­genase (5‐LOX) inhibition.     

Packing considerations of bis‐dimedone derivatives

We have determined the crystal structures of 2,2′‐(4‐fluoro­phenyl)­methyl­enebis(3‐hydroxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₃H₂₇FO₄, (I), 2,2′‐(4‐chloro­phenyl)­methyl­enebis(3‐hy­droxy‐5,5‐dimethyl‐2‐cyclo­hexen‐1‐one), C₂₃H₂₇ClO₄, (II), 2,2′‐(4‐hydroxy­phenyl)­methyl­enebis(3‐hydroxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₃H₂₈O₅, (III), 2,2′‐(4‐methyl­phenyl)­methyl­enebis(3‐hydroxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₄H₃₀O₄, (IV), 2,2′‐(4‐methoxy­phenyl)­methyl­enebis(3‐hy­droxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₄H₃₀O₅, (V), and 2,2′‐(4‐N,N′‐di­methyl­amino­phenyl)­methyl­enebis(3‐hydroxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₅H₃₃NO₄, (VI). Structures (III) to (VI) of these bis‐dimedone derivatives show nearly the same packing pattern irrespective of the different substituent in the para position of the aromatic ring. However, (II) does not fit into this scheme, although the Cl atom is a substituent not too different from the others. The different packing of the fluoro compound, (I), can be explained by the fact that it crystallizes with two mol­ecules in the asymmetric unit, which show a different conformation of the dimedone ring. On the other hand, (I) shows a similar packing pattern to bis(2‐hydroxy‐4,4‐di­methyl‐6‐oxo‐1‐cyclo­hexenyl)­phenyl­methane, a compound containing an aromatic ring without any substituent and with Z′ = 2.     

Three complexes of bis(N‐methyl­benzo­hydro­xamato‐O,O′)copper(II)

The first single‐crystal studies of three bis‐transoid Cu–hydrox­amate salts, bis(3‐methoxy‐4,N‐dimethyl­benzo­hydrox­amato‐O,O′)copper(II), [Cu(C₁₀H₁₂NO₃)₂], bis(4‐chloro‐N‐methyl­benzo­hydro­xamato‐O,O′)copper(II), [Cu­(C₈­H₇­Cl­NO₂)₂], bis(N‐methyl‐3,5‐di­nitro­benzo­hydro­xamato‐O,O′)copper(II)–chloro­form (1/2), [Cu­(C₈­H₆­N₃O₆)₂]·­2CHCl₃, are presented. The Cu atom in each of the title compounds sits at a center of inversion and displays a nearly square‐planar geometry with the hydro­xamate‐O atoms connected to it in a syn configuration. The N atoms are in a transoid configuration. Each five‐membered Cu–hydro­xamate ring is planar, thus providing evidence that a planar N atom is present in each ring. The phenyl groups are twisted with respect to the hydro­xamate group by ～40–54°. The angular strain of the sp² carbonyl oxy­gen is significant (～10° from ideal).